HIGHLIGHTS
- who: January et al. from the Military Institute of Medicine, Poland University, United States have published the Article: IL-1 and senescence: Friends and foe of EGFR neutralization and immunotherapy, in the Journal: (JOURNAL)
- what: The authors explored the effect of cetuximab in colorectal cancer in_vitro models and the antibody was able to increase senescence markers.
- future: Analysis and experiments are needed to understand all the dynamic puzzles which might be different between TKIs and moAbs that in the end convert senescence cells into resistant ones.
SUMMARY
In these . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.